Denali Therapeutics’ Post

Can the governance section in your annual report communicate more than just compliance? That's a big yes! Annual reports are more than checkboxes; they're an opportunity to showcase commitment across every section. 🌍 In Novozymes' 2022 Annual Report, I worked on further integrating sustainability into the governance section, explaining how the Board and executive leadership team champion sustainability. For example, the Chair, CEO, and each member of the executive team share how they drive sustainable practices in their respective areas. 🤝 It was great to see that these efforts were recently highlighted at the Annual Report Prize event at DI - Dansk Industri. 🙂 #annualreport #csrd #sustainability #financialcommunications #strategiccommunications https://lnkd.in/eeUgn_6x

Growing a Successful Company: Maintaining Culture and Vision Learn the best practices for maintaining company culture and vision while experiencing rapid growth. Hear from Manish K Chhabra CEO of a Hygenic Research Institute, as he shares his insights and experiences. Follow on Linkedin https://lnkd.in/g8Qkiy_d #CompanyCulture #VisionaryLeadership #SuccessfulGrowth #MaintainingCulture #BusinessSuccess #LeadershipTips #TeamBuilding #BestPractices #BusinessGrowth #RapidGrowth

"Leadership skills constantly evolve. For me, one key is humility. Many people think that leaders, Chief Executive Officers, they know it all. That’s not true at all for me: You learn from your team." 🤝 💡 Our CEO Thierry BERNARD recently joined the Excellerator 2023 of youth-led nonprofit Global Biotech Revolution to share his thoughts on leadership. See the whole interview here: https://lnkd.in/eKeUdwb2 What are your views on leadership? 🌟 Let us know in the comments! 👇

Another good, quick read on a pressing topic in Biopharma - TA and Portfolio Strategy, a critical part of enterprise strategy for any innovative firm (thanks Clemens Moeller, Ph.D.!):

🌐 Embracing a Culture-Centric Approach in Nonprofit Leadership 🌟 The recent piece on Novo Nordisk underscores the power of culture in fostering innovation and driving success. Like Novo Nordisk's commitment to a culture of collaboration and patient-centricity, non-profits can achieve remarkable outcomes by prioritizing values and character. 🚀 In the nonprofit sector, where our mission is to make a positive difference, building a culture that aligns with our core values is crucial. Strategy may guide us, but culture empowers us. The shared beliefs, attitudes, and behaviors define who we are and how we work toward our goals. 💡 Let's reflect on how we can cultivate a culture that amplifies our impact and attracts passionate individuals who resonate with our mission. How do we foster an environment where creativity thrives, and collaboration becomes second nature? 🌱 As leaders, let's lead by example, embodying our values. Our character, demonstrated through our actions, sets the tone for the entire organization. By placing culture at the forefront, we create a resilient foundation that withstands challenges and propels us towards our vision. Read the insightful article here: https://lnkd.in/gDbSt3bC Let's continue the conversation on the importance of culture in driving nonprofit success! Share your thoughts and experiences below. Together, we can shape a future where our impact is not just measured by numbers but by the enduring legacy of our shared values. 🌍💙 #NonprofitLeadership #CultureOverStrategy #MissionDriven #LeadershipMatters

TOMORROW at 11am ET, our CEO Dinesh V. Patel, PhD and other experienced thought leaders will discuss the key ingredients to creating high-value biotechs in a free webinar presented by BioCentury Inc. and Oppenheimer & Co. Inc. They will explore questions such as: What are the keys to building sustainable high-value biotechs? What is required for biotechs to jump market cap tier? And what are the principal challenges faced by today’s CEOs? Register today: #biotech | #leadership

Content so good I should not be giving it out for free (don't tell my boss). Welcome to Part 1 in our "Scrip Asks" article series where we invite industry leaders, investors, experts and other stakeholders to share their expectations for the year ahead. With responses from hundreds of professionals, "Scrip Asks…What Does 2024 Hold For Biopharma?" provides an exceptional insight, both broad and deep, into the biopharma universe’s collective crystal ball. Part 1 is on Business Strategy And Leadership with exclusive insights you won't find anywhere else from: Johnson & Johnson, AbbVie, Genmab, Gilead Sciences to name a few! #biopharma #strategy #innovation

Wondering what's on the minds of senior supply chain leaders in Life Sciences? Recently, senior leaders in Life Sciences Supply Chains in Switzerland came together at MSD Switzerland in Lucerne for our 3rd Deloitte peer-to-peer roundtable. We discussed two of the current key topics in our industry - 💡 How to make our supply chains & operations sustainable 💡 how to use the potential of GenAI and manage its implication on operations and organizations Thanks to the participants for the lively, engaging and insightful conversations. We would also like to thank Carolien van Bloemendal for hosting us and creating the space for us to connect and exchange different views. We look forward to meeting again for our next roundtable. Nico Sacco Mark Talens Marc Verpaele Xavier Baville Wim De Jonge Lieven Comeyne Aakash Deep ➡ If you would like to join the conversation, please reach out to me for further details. #roundtable #lifesciences #supplychain #sustainability #GenAI #jointheconversation